Nichols William Garrett (CIK 0001618364)

Latest company ownership

CADL - Candel Therapeutics, Inc.

Role: Chief Medical Officer

Shares held

937

Last filed at

Jul 30, 2025

Confidence Score

49.1

2025Q4

Confidence Score History

2023Q4 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Jul 28, 2025	Jul 30, 2025	Candel Therapeutics, Inc.	Chief Medical Officer	Sell	50.0	-937	-1.75%	✓	$6.5K
Jun 30, 2025	Jul 2, 2025	Candel Therapeutics, Inc.	Chief Medical Officer	Sell	50.0	-781	-1.47%	✓	$3.9K
Mar 18, 2025	Mar 20, 2025	Candel Therapeutics, Inc.	Chief Medical Officer	Sell	7.5	-45,316	-46.33%	✓	$397K
Jan 15, 2025	Jan 17, 2025	Candel Therapeutics, Inc.	Chief Medical Officer	Sell	42.5	-10,428	-11.62%	✗	$75.3K
Jan 8, 2025	Jan 10, 2025	Candel Therapeutics, Inc.	Chief Medical Officer	Sell	42.5	-10,799	-10.74%	✗	$88.7K
Nov 29, 2024	Dec 3, 2024	Candel Therapeutics, Inc.	Chief Medical Officer	Sell	42.5	-13,935	-12.17%	✗	$63.5K
Jul 17, 2024	Jul 19, 2024	Candel Therapeutics, Inc.	Chief Medical Officer	Sell	42.5	-10,875	-8.68%	✗	$70.4K
Jul 11, 2024	Jul 15, 2024	Candel Therapeutics, Inc.	Chief Medical Officer	Sell	42.5	-9,769	-7.23%	✗	$58.4K
Nov 28, 2023	Nov 30, 2023	Candel Therapeutics, Inc.	Chief Medical Officer	Sell	46.3	-12,175	-8.27%	✗	$11K